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Associations of mortality with 
own blood pressure using son’s 
blood pressure as an instrumental 
variable
David Carslake1,2, Abigail Fraser1,2, Margaret T. May2, Tom palmer  3, Karri silventoinen4, 
per tynelius5, Debbie A. Lawlor1,2 & George Davey smith1,2
High systolic blood pressure (sBp) causes cardiovascular disease (CVD) and is associated with mortality 
from other causes, but conventional multivariably-adjusted results may be confounded. Here we used 
a son’s sBp (>1 million Swedish men) as an instrumental variable for parental SBP and examined 
associations with parents’ cause-specific mortality, avoiding reverse causation. The hazard ratio for 
CVD mortality per SD (10.80 mmHg) of SBP was 1.49 (95% CI: 1.43, 1.56); SBP was positively associated 
with coronary heart disease and stroke. SBP was also associated positively with all-cause, diabetes and 
kidney cancer mortality, and negatively with external causes. Negative associations with respiratory-
related mortality were probably confounded by smoking. Hazard ratios for other causes were imprecise 
or null. Diastolic blood pressure gave similar results to SBP. CVD hazard ratios were intermediate 
between those from conventional multivariable studies and Mendelian randomization and stronger 
than those from clinical trials, approximately consistent with an effect of exposure duration on effect 
sizes. Plots of parental mortality against offspring SBP were approximately linear, supporting calls for 
lower SBP targets. Results suggest that conventional multivariable analyses of mortality and SBP are 
not substantially confounded by reverse causation and confirm positive effects of SBP on all-cause, CVD 
and diabetes mortality.
Higher blood pressure (BP) resulted in an estimated 10 million deaths and 212 million disability-adjusted life 
years globally in 20151. Randomised control trial (RCT) and Mendelian randomization (MR) analyses show that 
higher BP causes mortality from cardiovascular diseases (CVD) including coronary heart disease (CHD) and 
stroke2–6, supporting the results of numerous prospective cohort studies7–12. Higher BP has also been associated 
with mortality from external causes (accidents, homicides and suicides)13, renal disease14, all-site cancer15–17 and 
with several site-specific cancers18–23, including a strong positive association with kidney cancer15,22,24–26.
It is not clear whether these non-CVD outcomes are causally affected by BP or whether there is some con-
founding factor that affects both BP and survival. Potential confounding factors include aspects of behaviour, 
socioeconomic circumstances and the presence of pre-existing undiagnosed disease (sometimes called reverse 
causation). Reduced BP will only result in improved survival if the association between them is causal. Limited 
MR results suggest that higher BP is causally related to the risk of type 2 diabetes27, but not kidney disease6.
Current advice in the UK is to reduce the BP of hypertensive patients to a target of 140/90 mmHg in adults 
under 80 years old, and to 150/90 mmHg in older adults28,29. However, two major meta-analyses of prospective 
studies of BP and CVD7,11 have suggested that further reductions, to at least 115/75 mmHg, are beneficial to health 
and the apparent thresholds found in some prospective studies may have been due to confounding by pre-existing 
disease30,31. RCTs of antihypertensive drugs32–35 rarely include those with lower baseline BP, but mostly indicate 
that reduction to below 140/90 mmHg would reduce CVD mortality, with one study2 suggesting an advantage in 
reductions to 110/70 mmHg. BP target values are the subject of ongoing debate2,32,36–38.
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Here, we estimate the effect of BP on all-cause and cause-specific mortality using a son’s BP as an instrumental 
variable (IV) for their parent’s BP. An IV is a variable that is associated with the exposure of interest, but not with 
the factors confounding the association between the exposure and outcome. It can therefore be used to estimate 
causal effects in the presence of confounding. In MR, the IV is a genetic variant associated with the person’s (usu-
ally lifelong) exposure. We use the BP of a person’s son in the same way. A son’s BP is correlated with their parent’s 
BP but is unlikely to be affected by the parent’s existing, but undiagnosed, illness. This approach may also avoid 
some socioeconomic and behavioural confounding, but not all, since socioeconomic position and health-related 
behaviours track across generations. We compare our results with those from RCTs of anti-hypertensive treat-
ments, MR and conventional multivariable analyses of prospective cohorts to explore evidence for different 
potential causes of bias and duration of exposure to higher BP across these studies. We also examine the shape of 
the association between son’s BP and parental mortality for any evidence of a threshold.
Results
Description of study sample by quintiles of blood pressure. The standard deviations (SD) of son’s 
BP (used to convert all BP to SD units) were 10.80 mmHg for systolic blood pressure (SBP) and 9.22 mmHg for 
diastolic blood pressure (DBP). In the main dataset, sons with higher SBP or DBP had greater height and BMI 
and were less likely to smoke (Supplementary Tables S2 and S3). Their fathers also had greater height, BMI and 
BP and were less likely to smoke. Their mothers and fathers were born earlier, had lower educational and occu-
pation socio-economic position (SEP) and were older when the son was born. Results within the data subset 
with data on father’s BP were similar, except that sons with higher SBP (but not DBP) had parents of higher SEP 
(Supplementary Tables S4 and S5). Characteristics of sons, fathers and mothers varied similarly with father’s BP 
(Supplementary Tables S6 and S7).
Two-sample IV estimates for parental mortality. In the main dataset, there were 152,575 maternal 
deaths and 281,489 paternal deaths from all causes. The mean differences in father’s BP per SD of son’s BP (used 
as denominators in the IV ratios) are shown in Table 1. These associations were strong, approximately linear 
(Supplementary Fig. S2) and changed little with adjustment for the father’s SEP and/or the son’s BMI (Table 1).
Two-sample IV analysis suggested a modest association between SBP and all-cause mortality (HR per SD: 
1.11, 95% CI: 1.09, 1.14) which did not differ between mothers and fathers (Fig. 1, Supplementary Table S8). 
Reasonably well-powered results for CVD, CHD, stroke and diabetes suggested stronger positive associations. 
SBP had a strong negative association with external causes and suicide mortality and weaker negative associa-
tions with mortality from respiratory diseases (fathers only) and lung cancer. Very strong positive associations 
with cancers of the oesophagus and kidney were apparent only in mothers and a strong positive association with 
thyroid cancer was imprecisely estimated (Supplementary Table S14). Precision for many site-specific cancers was 
too low to allow confident interpretation.
Two-sample IV analyses of DBP (Fig. 2, Supplementary Table S9) showed a positive association with all-cause 
mortality (HR per SD: 1.39, 95% CI: 1.30, 1.48) that was stronger than that observed for SBP. Positive associations 
with CVD, CHD, stroke and diabetes were also greater. Unlike for SBP, there was a strong but imprecise positive 
association with kidney disease, which was most apparent in mothers. The negative association of SBP with exter-
nal causes and suicide mortality was also apparent with DBP among mothers, but not fathers, and there was no 
apparent association of DBP with respiratory diseases. There was again a negative association with lung cancer 
and a positive association with kidney cancer which matched those of SBP, albeit with very low power in the latter. 
Positive associations of DBP with liver cancer and malignant melanoma (Supplementary Table S15) were only very 
weakly repeated for SBP (Supplementary Table S14). A sex-specific association with oesophageal cancer (positive 
in mothers, negative in fathers) was apparent for both SBP and DBP, albeit with very low precision in both cases.
Two-sample IV analyses that were not adjusted for SEP (Supplementary Tables S10 and S11) gave slightly 
higher hazard ratios (i.e. stronger positive ones and weaker negative ones) but the differences were not sufficient 
to change interpretation materially. Additional adjustment for son’s BMI substantially attenuated IV hazard ratios 
for diabetes mortality (e.g. from 1.78 (95% CI: 1.49, 2.13) to 1.29 (95% CI: 1.08, 1.55) for SBP), but had a relatively 
Blood pressure
Regression of father’s blood pressure (SD) against son’s blood pressure (SD)
Adjustment
Mean difference 
(95% CI) F-statistic R2
SBP None 0.130 (0.122, 0.137) 1121.8 0.0166
SBP Father’s SEP 0.131 (0.123, 0.138) 145.5 0.0193
SBP Father’s SEP, son’s BMI 0.128 (0.120, 0.135) 134.4 0.0199
DBP None 0.060 (0.053, 0.067) 278.8 0.0042
DBP Father’s SEP 0.060 (0.053, 0.067) 36.1 0.0049
DBP Father’s SEP, son’s BMI 0.059 (0.052, 0.066) 38.1 0.0057
Table 1. Mean differences in father’s blood pressure per standard deviation (SD) of son’s blood pressure. 
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were each pre-adjusted for regional 
patterns, secular trends and age at examination. Blood pressure in fathers and sons was analysed in SD units 
(10.80 mmHg SBP and 9.22 mmHg DBP). Mean differences were obtained from linear regression and provide 
the denominators for the ratio method instrumental variable estimates. N = 66,567. F-statistics and R2 are 
provided as measures of instrument strength.
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small effect for other causes of death (Supplementary Tables S12 and S13). There was strong evidence suggesting 
that the positive association between a son’s BP and parental all-cause mortality (except for DBP and fathers) 
increased with the parent’s age, but hazard ratios from follow-up split at 60 years old (Supplementary Tables S18 
and S19) suggested that the magnitude of the difference may have been minor. For most specific causes of mortal-
ity, there was no strong evidence of non-proportional hazards.
One-sample IV estimates for parental mortality. Hazard ratios from one-sample IV analyses in the 
subset with data on father’s BP (Tables 2 and 3, Supplementary Tables S16 and S17) were broadly similar to the 
corresponding estimates from two-sample IV analyses (Figs 1 and 2, Supplementary Tables S8 and S9), but were 
imprecise and hazard ratios could not confidently be distinguished from the null. Conventional multivariable 
analyses of father’s BP in this subset were a little more precise and showed positive associations of SBP and DBP 
with CVD, CHD and stroke mortality. The results were weakly suggestive of negative associations with mortality 
from external causes, suicide and lung cancer. Conventional multivariable hazard ratios for all-cause mortality 
were close to the null, with reasonable precision (HR per SD: 1.03, 95% CI: 0.99, 1.07 for SBP and HR per SD: 
1.01, 95% CI: 0.97, 1.06 for DBP). Estimation of hazard ratios by conventional multivariable and IV methods 
in the same dataset allows their comparison by Durbin-Wu-Hausman test. There was no evidence that the two 
methods gave different estimates, regardless of the outcome, exposure or adjustment, although this should be 
interpreted in the context of the very low precision of the one-sample IV estimates.
Shape of the associations between son’s blood pressure and parental mortality. As well as provid-
ing the numerator of the linear IV ratio (Figs 1 and 2, Supplementary Tables S8–S13) the association between son’s 
BP and parental mortality can be plotted to indicate the likely shape of the association between BP and mortality 
with some sources of confounding removed (Fig. 3, Supplementary Fig. S3). Paternal mortality from all-causes, 
CVD, CHD, stroke, external causes and suicide was approximately linear across the observed ranges of son’s SBP and 
DBP. In mothers, there was some suggestion that the positive associations of son’s SBP with mortality from all causes, 
CVD, CHD and stroke leveled off below approximately 120 mmHg, and that the association of DBP with diabetes 
mortality leveled off below about 70 mmHg. However, wide confidence intervals, particularly at lower BP, left some 
uncertainty in the shape of the associations. Plotted associations for the rarer causes of death were very imprecise.
Figure 1. Adjusted hazard ratios (HR) for parental mortality per standard deviation (SD) of own SBP, using 
son’s SBP as an instrumental variable (IV). SBP was pre-adjusted for regional patterns, secular trends and age 
at examination and its SD was 10.80 mmHg. Cox proportional hazards models with age as the time axis were 
adjusted for parental sex and for educational and occupational socioeconomic position. Robust standard errors 
were clustered by the son’s identity. PM vs F was derived from a Z-test of an additional interaction term between 
parental sex and son’s SBP. Two-sample IV estimates were made using the ratio method. Mothers and fathers 
were also modelled separately, without the robust standard errors or the adjustment for parental sex. Plotted 
data are tabulated in Supplementary Table S8. N = 1,002,031 mothers and 986,075 fathers at risk of mortality.
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Discussion
Using a son’s BP as an IV for his parents’ BP, we confirmed clear positive associations of SBP and DBP with death 
from all-causes, CVD, CHD, stroke and diabetes. SBP (and to a lesser extent DBP) had strong, negative associa-
tions with suicide and external causes of death and weaker negative associations with death from lung cancer and 
respiratory disease. Several other causes of death, particularly from rarer cancers, showed suggestive associations 
which were estimated imprecisely and were often inconsistent between men and women, or between SBP and DBP.
Do hazard ratios using son’s blood pressure as an IV estimate the causal effect of blood pres-
sure on mortality? IV methods give estimates which reflect the causal effect of the exposure (here, the par-
ent’s own BP) on the outcome (here, the parent’s survival) if some important assumptions are met39. In particular, 
the untestable assumption is made that the instrument is not associated with any unmeasured factors confound-
ing the relationship between the exposure (parents BP) and outcome (mortality). Here this assumption is likely 
to be violated because a son’s socioeconomic position and characteristics associated with it, such as smoking, are 
likely to be associated with these same characteristics in the parents.
Although adjustment for the few socioeconomic covariates which were measured did not greatly affect the 
IV estimates of the association between mortality and BP in parents (compare Supplementary Tables S8 and S9 
with Supplementary Tables S10 and S11), we cannot assume that these reflect all unmeasured confounding. In 
particular, the inverse association of BP with respiratory diseases and lung cancer in our IV analyses is probably 
due to the association of son’s BP with smoking in the parents. Smoking is strongly associated with increased 
mortality from these causes and is positively associated between generations. Most studies have found smoking 
to be associated with reduced BP40–42, though it is not clear if this association is causal43. The limited dichotomous 
smoking data available in the present study also suggest a negative association with BP but were too sparse to be 
used in adjustment. Furthermore, we had no data at all on more detailed measures of smoking (e.g. pack-years 
or cotinine levels).
When effects of exposure on outcome are estimated in IV analyses, any biases in the association between 
instrument and outcome due to such confounding will be amplified in inverse proportion to the strength of the 
instrument-exposure association44. An IV analysis may therefore be more biased than the analogous conventional 
multivariable analysis even if the unmeasured confounder is more closely associated with the exposure than it is 
Figure 2. Adjusted hazard ratios (HR) for parental mortality per standard deviation (SD) of own DBP, using 
son’s DBP as an instrumental variable (IV). DBP was pre-adjusted for regional patterns, secular trends and age 
at examination and its SD was 9.22 mmHg. Cox proportional hazards models with age as the time axis were 
adjusted for parental sex and for educational and occupational socioeconomic position. Robust standard errors 
were clustered by the son’s identity. PM vs F was derived from a Z-test of an additional interaction term between 
parental sex and son’s DBP. Two-sample IV estimates were made using the ratio method. Mothers and fathers 
were also modelled separately, without the robust standard errors or the adjustment for parental sex. Plotted 
data are tabulated in Supplementary Table S9. N = 1,002,031 mothers and 986,075 fathers at risk of mortality.
5Scientific RepoRts |          (2019) 9:8986  | https://doi.org/10.1038/s41598-019-45391-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
with the instrument45. Although son’s BP is a stronger instrument than most of the genetic instruments used in 
MR46, it is more likely to be associated with factors confounding the association between BP and mortality. It is 
also considerably weaker than other offspring characteristics (height, BMI) previously used as IVs for the same 
characteristic in their parents47,48. It therefore seems likely that these IV estimates for BP are subject to at least as 
much bias from socioeconomic confounding as conventional multivariable estimates are. We therefore present 
these IV estimates not as unconfounded, but as differently confounded. They may be interpreted alongside esti-
mates from other methods to improve causal inference under the principles of triangulation49.
While the present estimates may be vulnerable to socioeconomic confounding, reverse causation (i.e. con-
founding from pre-existing disease) should not be a problem, since a medical condition in the parents is unlikely 
to have a major effect on their son’s adult BP (Fig. 4). There is evidence30,50–52 suggesting reverse causation acting 
on BP up to three years prior to death, but it is not clear whether chronic, sub-clinical conditions can lower BP 
earlier than this. Conventional multivariable analyses in which BP is measured at a young age may therefore have 
limited vulnerability to reverse causation, but we consider offspring BP to be an instrument for lifelong BP in 
the parents, including in old age when reverse causation is likely to be important in conventional multivariable 
analyses.
Comparison with other studies. This study confirms the positive associations of high BP with mortality 
from CHD and stroke previously found using MR, RCTs and conventional multivariable analyses2–12. One previ-
ous study53, using Norwegian data from the HUNT cohort, has estimated associations between BP and mortality 
using offspring BP as an IV. In that study, the offspring’s BP was measured at a rather later age (mean 29.5 years 
compared to 18.3 here) which may account for the greater SD in SBP (16.6 mmHg in men, compared to 10.8 here; 
SD of DBP was similar in the two studies). Lower power meant that only four causes of death were considered in 
the earlier study and all four, as in the present study, were positively associated with BP. Considered per SD, they 
found similar HR for all-cause mortality to the present study, rather lower HR for CVD and CHD mortality, and 
for stroke mortality the HR per SD of SBP were similar to the present study but those per SD of DBP were rather 
lower. When the HR per SD of SBP were converted to HR per mmHg, those for CVD and CHD were considerably 
lower than those in the present study; for example the HR for CHD mortality per 10.8 mmHg SBP was 1.19 (95% 
CI: 1.10, 1.29) compared to the analogous HR here (Fig. 1, Supplementary Table S8) of 1.66 (95% CI: 1.57, 1.75). 
These differences may be due to the more comprehensive adjustment possible in the earlier study or to the more 
advanced age of both offspring at BP measurement and parents during follow-up.
Our results for SBP and CHD may be compared with those of Ference et al.4, who meta-analysed analogous 
results from RCTs (relative risk reduction (RRR) per 10 mmHg lower SBP: 17%; 95% CI: 10%, 24%), prospective 
cohort studies (RRR: 25%; 22%, 29%) and MR (RRR: 46%; 32%, 56%). Our result (RRR per 10 mmHg lower SBP: 
37%; 34%, 40%) is intermediate between those for cohort studies and MR. Arguably, the duration of exposure in 
the present IV study is also intermediate between the values for cohort studies and MR in Ference et al., which 
would be consistent with the suggestion4 that effect estimates increase in proportion to the duration of exposure 
in different study types.
The associations with CHD were a little stronger than most results from conventional multivariable analyses. 
For example, we found an IV hazard ratio per SD of SBP of 1.66 (95% CI: 1.57, 1.75), compared with 1.39 (1.38, 
1.41) in the largest meta-analysis to date54 (taking the 60–69 age group which most closely matches the mean age 
at death in our data, and converting hazard ratios to our units). In contrast, at 1.25 per SD of SBP (95% CI: 1.16, 
1.35) our hazard ratio for stroke mortality was rather smaller than that in the same meta-analysis, which was 
1.58 (1.54, 1.62). Besides the possible effect of duration of exposure mentioned above, these differences could 
reflect cause-specific differences in the bias remaining under each methodology or could simply be due to pop-
ulation differences. The hazard ratios found in the meta-analysis above were very similar to those found in an 
Cause of death Deaths
HR (95% CI) per SD 
of own SBP
IV HR (95% CI) per 
SD of own SBP Pown vs IV
All cause 2,332 1.03 (0.99, 1.07) 1.01 (0.74, 1.37) 0.873
Cardiovascular disease 423 1.21 (1.11, 1.33) 1.34 (0.65, 2.77) 0.779
Coronary heart disease 235 1.23 (1.09, 1.39) 1.91 (0.72, 5.04) 0.373
Stroke 86 1.21 (0.99, 1.48) 1.92 (0.39, 9.56) 0.568
External causes 1,065 0.97 (0.92, 1.03) 0.94 (0.60, 1.48) 0.884
Suicide 466 0.95 (0.87, 1.04) 0.87 (0.44, 1.72) 0.780
Cancer 428 1.04 (0.95, 1.15) 1.00 (0.48, 2.05) 0.898
Brain cancer 61 1.15 (0.91, 1.47) 0.31 (0.05, 2.09) 0.174
Lung cancer 59 0.85 (0.66, 1.10) 1.24 (0.18, 8.66) 0.698
Lymphatic cancer 64 1.02 (0.80, 1.30) 0.35 (0.05, 2.24) 0.255
Table 2. Adjusted hazard ratios (HR) for paternal mortality (i) per standard deviation (SD) of own systolic 
blood pressure (SBP) and (ii) per SD of own SBP, using son’s SBP as an instrumental variable (IV) within 
the subset having data on own SBP. SBP was pre-adjusted for regional patterns, secular trends and age at 
examination and its SD was 10.80 mmHg. Cox proportional hazards models with age as the time axis were 
adjusted for educational and occupational socioeconomic position. One-sample IV estimates were made using 
the ratio method. Pown vs IV was derived from Durbin-Wu-Hausman tests comparing the two HR. N = 66,567 
fathers at risk of mortality. Rarer causes of death (<50 deaths in the data subset) are omitted.
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independent meta-analysis of Asia-pacific cohorts11, but a more recent study of a single large UK cohort12 found 
much smaller associations, which may be due to the increasing use of antihypertensive medication50.
High BP has previously been associated with increased mortality from external causes, including suicide13. In 
contrast, our IV analyses suggested a strong negative association with SBP in both sexes and with DBP in moth-
ers; high BP appeared to be protective against external causes and suicide mortality. A previous conventional 
multivariable analysis using much of the same data as the present study10 found a positive association of DBP (but 
not SBP) with suicide but negative associations of SBP and DBP with other external causes mortality. Low BP is 
associated with impaired cognitive performance55, anxiety and depression56 and fainting57, all of which provide 
plausible causal pathways for a negative association between BP and external causes mortality. Positive associa-
tions in previous studies could be due to confounding by psychologic distress, socioeconomic position or alcohol 
consumption13. Some of these sources of confounding might be reduced in the present study and in the previous 
study of similar data by the young age at which BP was recorded. Alternatively, differences between populations, 
particularly regarding the age of follow-up, could be responsible for the difference.
It has been suggested7 that the proportional effect of high BP on mortality declines with age; we found weak 
evidence supporting this for CHD and stroke mortality. The increasing HR with age that we found for all-cause 
mortality were probably due to the decreasing contribution of external causes mortality (against which high BP 
appears protective in our study) to total mortality as the parents aged.
Previous studies have found an association between high BP and increased incidence of, or mortality from, 
kidney disease14,58. We found a similar association for DBP which was rather stronger in women than in men. 
The association with SBP, however, was close to the null, albeit with sufficient imprecision that a positive associ-
ation of similar magnitude could not be ruled out (after conversion to our units, the Asia-Pacific Cohort Studies 
Collaboration found HR: 1.41, 95% CI: 1.31, 1.53 compared to our IV estimate of HR: 1.03, 95% CI: 0.79, 1.34). 
The extent to which high BP is a consequence, rather than a cause, of kidney disease remains uncertain6,59,60 but 
reverse causation is largely accounted for in our IV analysis. We also found positive, but rather imprecise, asso-
ciations of BP with kidney cancer which supports previous studies suggesting that high BP can also cause cancer 
in the kidneys.
Our IV results for any-site cancer were close to the null, but this appears to have been a consequence of pos-
itive and negative associations for several different site-specific cancers cancelling each other out. Power was 
generally low for site-specific cancers. Those that appeared associated with BP in one sex only, or with only one 
of SBP and DBP, should be interpreted with particular caution given the number of tests conducted. Our IV 
results for SBP and DBP suggested a negative association with lung cancer that was consistent between the sexes. 
By contrast, previous studies61,62 have suggested a positive association. As discussed above, our IV estimates of 
the association between higher BP and lung cancer mortality are probably biased downwards by confounding by 
smoking, which previous studies adjusted for.
The substantial attenuation of the IV estimates for diabetes when adjusted for son’s BMI suggests that these 
particularly strong positive associations may have been confounded by BMI, which is a particularly strong risk 
factor for diabetes63 and is associated between generations. Nonetheless, the attenuated HR was similar in magni-
tude to the positive effect of higher SBP on diabetes risk (approximate odds ratio per 10.80 mmHg: 1.24, 95% CI: 
1.11, 1.38) reported by an MR27.
Is there a threshold for the benefits of reduced blood pressure? If the associations between BP 
and mortality are taken to be causal, the presence or absence of a threshold below which reductions in BP are 
no longer beneficial is important for the optimal management of high BP33,36,38. Consistent with two major 
meta-analyses of prospective cohort studies7,11, we observed associations between son’s BP and paternal CHD 
mortality that were approximately log-linear across the observed range of BP. For maternal CHD mortality the 
Cause of death Deaths
HR (95% CI) per SD 
of own DBP
IV HR (95% CI) per 
SD of own DBP Pown vs IV
All cause 2,332 1.01 (0.97, 1.06) 0.69 (0.35, 1.35) 0.264
Cardiovascular disease 423 1.11 (1.00, 1.23) 1.23 (0.25, 5.95) 0.901
Coronary heart disease 235 1.13 (0.98, 1.29) 2.70 (0.32, 22.66) 0.419
Stroke 86 1.14 (0.91, 1.43) 3.62 (0.11, 122.51) 0.520
External causes 1,065 0.97 (0.91, 1.04) 0.69 (0.25, 1.87) 0.496
Suicide 466 0.98 (0.89, 1.08) 0.90 (0.20, 4.05) 0.910
Cancer 428 1.03 (0.93, 1.14) 0.59 (0.12, 2.83) 0.486
Brain cancer 61 0.97 (0.74, 1.27) 0.29 (0.00, 18.49) 0.569
Lung cancer 59 0.84 (0.64, 1.11) 1.11 (0.02, 76.55) 0.900
Lymphatic cancer 64 0.94 (0.73, 1.22) 0.06 (0.00, 3.21) 0.171
Table 3. Adjusted hazard ratios (HR) for paternal mortality (i) per standard deviation (SD) of own diastolic 
blood pressure (DBP) and (ii) per SD of own DBP, using son’s DBP as an instrumental variable (IV) within 
the subset having data on own DBP. DBP was pre-adjusted for regional patterns, secular trends and age at 
examination and its SD was 9.22 mmHg. Cox proportional hazards models with age as the time axis were 
adjusted for educational and occupational socioeconomic position. One-sample IV estimates were made using 
the ratio method. Pown vs IV was derived from Durbin-Wu-Hausman tests comparing the two HR. N = 66,567 
fathers at risk of mortality. Rarer causes of death (<50 deaths in the data subset) are omitted.
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confidence intervals at the lower end of the SBP distribution were wide enough to be consistent with a threshold 
at around 115/60 mmHg, or with an approximately linear association. No other causes of death showed clear 
evidence of a threshold. A previous study of this population10 found that CVD mortality ceased to decline with a 
subject’s own SBP and DBP below thresholds of about 120 mmHg and 70 mmHg, respectively. In the same study, 
the association with all-cause mortality reversed at low SBP such that the overall curve was U- or J-shaped. These 
differences may be attributed to the different patterns of confounding, or to the demographic changes in the 
population between the two studies. The fathers in our study were older on average than the men in the previous 
study (50 years old versus 42) and external causes mortality, negatively associated with BP in both studies, con-
tributed a smaller proportion (9% versus 50%) of the total mortality.
Figure 3. Plots of hazard ratio (HR; relative to the median blood pressure) for parental coronary heart disease 
(CHD) mortality against a son’s systolic (SBP) or diastolic (DBP) blood pressure. Son’s SBP and DBP were pre-
adjusted for regional patterns, secular trends and age at examination. Cox regressions with parental age as the 
time axis modeled SBP or DBP as cubic splines with 4 knots and were adjusted for the parent’s educational and 
occupational socioeconomic position. Shaded areas represent 95% confidence intervals. For clarity, plots are 
truncated at the 1st and 99th percentiles of SBP or DBP.
Figure 4. Directed acyclic graph illustrating potential confounders of the effect of blood pressure (BP) on 
mortality, when a son’s BP is used as an instrument. A conventional estimate of g (the effect of the exposure on 
the outcome) may be biased due to confounding via pathways such as cd and hi. An IV estimate of the same 
effect may be biased by confounding via pathway bad, and any such bias is magnified by the reciprocal of the 
association ef + bac between instrument and exposure. The IV estimate of g is likely to be biased by socio-
economic position (SEP; and other environmental or behavioural factors such as smoking behaviour which 
are associated between generations) but we argue that reverse causation (i.e. confounding by the parent’s 
health) is unlikely to bias the IV estimate. An unbiased instrumental variables analysis also requires that 
there be no pathway from instrument to outcome (except via the exposure) and that the association between 
instrument and exposure is non-null. In the present case, a causal effect of son’s blood pressure on parental 
BP is implausible; we must further assume that there is no causal effect of parental BP on son’s BP and that the 
common genetic and environmental factors (G/E) causing the instrument and exposure to be associated (ef) are 
distinct from those confounding the exposure and outcome.
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When considering the treatment of high BP, it should be noted that associations between BP and mortality, 
even if causal, may not apply in the same way to drug-induced changes in BP37. Furthermore, reduced BP and 
increased medication may impact upon quality of life, which becomes increasingly important at older ages.
Strengths and limitations of the study. The study followed survival among the parents of an almost 
complete cohort of Swedish men. This gave a very large sample which was highly representative of the recent 
population of Sweden. Those who do not have sons are the only substantial section of the population missing 
from the study. Biological mechanisms causally linking BP to mortality are likely to be similar in different pop-
ulations, but patterns of socioeconomic confounding might be different in populations outside Europe or even 
Scandinavia (the setting for both studies to date using this method). There was some evidence of digit preference 
in the BP measurements, which may result in a slight attenuation of the results towards the null. The availability 
of BP data in a subsample of fathers allowed the use of a son’s BP as an IV and not just as a proxy and was a par-
ticularly valuable feature of these data. By using a son’s BP as an IV, we were able to increase the follow-up time 
and to avoid confounding by pre-existing disease. The two major limitations of the IV approach are the risk of 
amplifying any remaining confounding and the reduction in power for the same sample size. The subsample of 
fathers with measured BP, although large by normal epidemiological standards, was not sufficient to make use-
fully powerful comparisons of the IV and conventional multivariable methods on comparable data. The absence 
of any BP data for mothers meant that two-sample IV estimates for mothers required the additional assumption 
that the mother-son association in BP was the same as the father-son association. There is some evidence that this 
is the case for SBP, but that a son’s DBP may be better associated with his father’s DBP than his mothers64,65. When 
comparing IV estimates for maternal and paternal mortality it should also be noted that they could be differently 
biased if, for example, a son’s health-related behavior and hence BP are more affected by unhealthy behaviour in 
the mother than by similarly unhealthy behaviour in the father. The father-son correlation in SBP in the present 
study was similar to that found in other studies, while the correlation in DBP was rather lower, and less than that 
typically found elsewhere64,65. Besides the amplification of confounding considered above, a weak association 
between the exposure and the instrument can lead to IV estimates being biased towards the conventional multi-
variable estimates. The sample size, however, led to reassuringly large F-statistics for the father-son associations.
Conclusions
Using a son’s BP as an IV for his parents’ BP, we found that son’s SBP and DBP were positively associated with 
mortality in both parents from all-causes, CVD, CHD, stroke and diabetes. SBP, but not DBP, was inversely asso-
ciated with mortality from external causes and specifically suicide. These results are approximately consistent with 
other published studies using subjects’ own BP and suggest that hazard ratios estimated by conventional multi-
variable methods are not substantially confounded by pre-existing ill-health. The negative associations found 
with respiratory disease and lung cancer contrast with the positive associations found by most conventional 
multivariable studies and were probably confounded by smoking. The limited evidence available to us suggests 
that these IV estimates are at least as vulnerable to socioeconomic and behavioural confounding as conventional 
multivariable estimates are. Other causal inference methods using observational data, such as MR, may give more 
reliable estimates of the causal effect of long-term differences in BP. When a son’s BP was plotted as a proxy for 
his parents’ BP, we found no strong evidence of a threshold below which the positive association between BP and 
CVD mortality was nullified or reversed.
Methods
Data preparation. The Swedish Multi-Generation Register provided the unique national identity numbers 
and dates of birth of all 1,629,396 males born in Sweden between 1951 and 1980 (Supplementary Fig. S1), and 
those of their biological parents. The identity numbers of the sons and fathers were linked to records from con-
scription examinations held between 1969 and 2001. Conscription examinations were compulsory for young 
Swedish men during this period, except for those with severe handicap or chronic disease. They took place at a 
mean age of 18.3 years (range 16 to 25, with 91% aged 17 or 18) at one of six regional conscription centres and 
provided data on examinees’ SBP, DBP, height and weight. Blood pressures were measured after 5–10 minutes’ 
rest in a supine position, with an appropriately sized cuff at heart level. Manual cuffs were used until 1995 in most 
examination centres, before replacement with automatic ones. If SBP was less than or equal to 145 mmHg and 
DBP between 50 and 85 mmHg, a single measurement was made. Otherwise, a second measurement was made 
and this value was recorded and used for analysis10. Data were missing for 17% of examinees, mainly due to 
accidental loss following administrative changes at the conscription authority. Smoking habits were available for 
29,485 examinations, mostly from 1969 or 1970.
The Swedish Cause of Death Register provided the underlying cause for the 281,489 paternal and 152,575 
maternal deaths which occurred between 1961 and 2004. These were converted from international classifica-
tion of diseases (ICD) codes into broad categories, some of which were nested within others (Supplementary 
Table S1). Emigrants were also identified, allowing the assumption that parents who were not dead or emigrated 
by 31st December 2004 were still alive at this date. The Swedish Population and Housing Census provided data 
on parental educational level and occupational status in 1970 and 1990. We took the higher of the 1970 and 1990 
values for educational level and classified it into five levels: <9 years; 9–10 years; full secondary education; ter-
tiary education; and missing (2.0% of mothers and 6.1% of fathers). We also classified parents according to five 
mutually exclusive categories of occupational status: high/intermediate non-manual; lower non-manual; skilled 
manual; unskilled manual; and other/missing. We used the 1970 value for parents born before 1935 and the 1990 
value for parents born later. 27.5% of mothers fell into the other/missing category, comprising 1.9% missing data, 
0.8% farmers and 24.9% others (including housewives, students, pensioners and part-time workers). 17.2% of 
fathers were categorised as other/missing, comprising 4.7% missing, 4.0% farmers and 8.5% others.
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To avoid pseudoreplication within families, only one son from each parent was retained in the database. 
Retention was random except that whenever possible, the same son was retained for both his parents. Our main 
analyses were thus conducted on 986,075 father-son pairs and 1,002,031 mother-son pairs. In 66,567 father-son 
pairs, the father’s BP (measured at his own conscription examination at age 18) was also available. This subset of 
the data was used to quantify the intergenerational association of BP and for other analyses requiring data on the 
father’s BP (Supplementary Fig. S1).
Statistical analysis. Analyses described below were conducted separately for SBP and DBP (which we 
refer to collectively as BP). Before all further analysis, son’s BP was adjusted for regional patterns, secular trends 
and the effect of age at examination by taking residuals from a regression of son’s BP on regional conscription 
centre (categorical variable with six levels) and cubic splines of age at examination and date of birth (7 knots at 
percentiles of 2.5, 18.3, 34.2, 50, 65.8, 81.7 and 97.5)66. A similar adjustment was applied to father’s BP, where 
available, and both were divided by the SD of adjusted BP in sons. Sons’ and parents’ characteristics were sum-
marised by quintiles of son’s adjusted BP and linear or logistic regression was used to examine associations as 
appropriate.
We estimated the effect of parents’ own BP on their mortality using the ratio method in two-sample instru-
mental variable (IV) analyses39. If certain assumptions are met, IV methods allow the estimation of causal effects 
free from confounding and reverse causation. The instrument was son’s BP. In IV estimates made by the ratio 
method the numerator is the association between the outcome and the instrument and the denominator is the 
association between the exposure and the instrument. Since BP was not measured in women, IV estimates for 
mother’s mortality used a denominator based on the father-son association in BP. The denominator was estimated 
in the subset of data for which the father’s BP was available (N = 66,567; Supplementary Fig. S1). Linear regres-
sion provided the mean difference in father’s BP (in SD units) per SD of son’s BP, with and without additional 
adjustment for the father’s occupational status and educational level, which we refer to collectively as socioeco-
nomic position (SEP). The numerator was estimated in the main dataset in which father’s BP was not required 
(N = 986,075 father-son and 1,002,031 mother-son pairs; Supplementary Fig. S1). Cox proportional hazards 
models were used to estimate the natural logarithms of hazard ratios (HR) for all-cause and cause-specific paren-
tal mortality per standard deviation (SD) of son’s BP. Initial models analysed parents of both sexes together, with 
adjustment for parental sex and robust standard errors clustered by the son’s identity. Parental age was used as the 
time axis and models were run with and without additional adjustment for SEP. Observations were right-censored 
at the earliest of parent’s date of death or emigration, or on 31st December 2004 (the end of follow-up). They were 
left-truncated at the latest of the son’s date of birth or 1st January 1961 (the start of follow-up). To test whether 
the associations with son’s BP differed between mothers and fathers, parent’s sex was further allowed to interact 
with son’s BP and SEP (if included). Separate analyses were also conducted for mothers and fathers, omitting 
adjustment for parent’s sex and the clustered robust standard errors. Ratio method IV estimates made using 
similar adjustment in the numerator and denominator were exponentiated to provide IV estimates of the HR for 
parental mortality per SD of their own BP. Confidence intervals were calculated using Taylor series expansions67. 
To test the proportional hazards assumption, correlation coefficients between the parent’s age and the Schoenfeld 
residuals were calculated. Follow up was also split to estimate separate hazard ratios for parents before and after 
their 60th birthday. To test whether associations were confounded by body mass index (BMI), we conducted a sen-
sitivity analysis in which the IV numerator and denominator were additionally adjusted for son’s BMI (parental 
BMI was not available in the main dataset).
The IV estimates assume linearity in the associations making up both the numerator and the denominator. 
This assumption was tested in the denominator by plotting mean father’s BP in centiles of son’s BP. For the numer-
ator, sex-specific Cox models were estimated as described above, except that son’s BP was represented by a cubic 
spline with knots at the 5th, 35th, 65th and 95th percentiles66 for comparison with previously published results for 
own BP10.
Two-sample IV optimises power, but we may also wish to test whether IV estimates differ from analogous 
estimates made by a conventional multivariable analysis of parents’ own BP. For this purpose, one-sample IV 
estimates (where the numerator and denominator are estimated from the same sample) were made using the sub-
sample of data in which father’s BP was known (Supplementary Fig. S1) and compared with conventional multi-
variable HR for a father’s mortality against his own BP. The one-sample IV estimates were made in exactly the way 
described above for the father-specific two-sample IV estimates. The conventional multivariable estimates were 
made with the same time axis, truncation, censoring and adjustment and were compared to the one-sample IV 
estimates using Durbin-Wu-Hausman tests68.
Statistical analyses were performed using Stata 14.1 on the University of Bristol supercomputer Blue Crystal 
and Stata 15.1 on a desktop machine. The study was performed in accordance with relevant guidelines and regu-
lations and was approved by the Research Ethics Committee of the University of Bristol Faculty of Health Sciences 
(55841). Swedish national law and European guidelines do not require informed consent for research based on 
non-identifiable register-based data.
Data Availability
Swedish privacy laws prohibit us from making individual-level data publicly available. Researchers who are inter-
ested in replicating our work using individual-level data should apply to the appropriate Swedish authorities e.g. 
Statistics Sweden. For more information, see https://www.scb.se/en/services/guidance-for-researchers-and-uni-
versities/.
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